Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.
Press releases published on August 12, 2025
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 12, 2025
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission in systemic lupus erythematosus (DORIS …
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
GlobeNewswire
·
August 12, 2025
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to …
Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
GlobeNewswire
·
August 12, 2025
Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% …
floLIVE Launches Seamless Cross-Border Cellular IoT Service Spanning Africa’s Logistics Corridors
EIN Presswire
·
August 12, 2025
Solution delivers high-volume cross-border connectivity supporting video telematics, network infrastructure, and fleet safety at significantly lower costs LONDON, UNITED KINGDOM, August 12, 2025 /EINPresswire.com/ -- floLIVE, a global enabler of IoT …
PE Energy Limited Celebrate Major Milestone in Local Content Development with Successful Graduation of HCD Trainees
EIN Presswire
·
August 12, 2025
PE Energy, with Chevron …
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
GlobeNewswire
·
August 12, 2025
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today that it has commenced purchases of Ethereum (ETH), advancing its …
Rio Silver Amends Maria Norte Terms
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to the announcements on March 26 and June 25, 2025 (collectively, the “Prior Announcements”), …
Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton
GlobeNewswire
·
August 12, 2025
ASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the release of the fourth …
Critical Metal Corps Strengthens Management Team With Appointment of Mathias Barfod as President of Greenland Operations
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced the appointment of Mathias Barfod as the Company’s President of …
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
GlobeNewswire
·
August 12, 2025
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and Ligand Achieved multiple FDA …
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
GlobeNewswire
·
August 12, 2025
Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, APR-1051 $16.5 million in cash and cash equivalents as of …
Cerevance to Participate in Piper Sandler Virtual CNS Symposium
GlobeNewswire
·
August 12, 2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation at the Piper Sandler …
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
GlobeNewswire
·
August 12, 2025
In a gold-standard model of obesity, treatment with ARD-201 resulted in approximately 19% body weight reduction after 30 days of treatment. ARD-201 was also associated with attenuated weight regain after discontinuation of tirzepatide. In combination with …
Century Announces Filing of First Quarter Financial Results and Management Discussion and Analysis for the Three Months Ended June 30, 2025
GlobeNewswire
·
August 12, 2025
HONG KONG, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the first fiscal quarter ended …
Integral Metals Provides Update on 2025 Drilling at the KAP Project
GlobeNewswire
·
August 12, 2025
CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to provide an update on its 2025 diamond drilling program at the KAP Project in the Northwest Territories …
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
August 12, 2025
Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 Cash of $56.1 million as of June 30, 2025, expected to support operations into 2027 LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma …
Westkam Gold Corp. Provides Update on Management Cease Trade Order
GlobeNewswire
·
August 12, 2025
Vancouver, BC, Canada, Aug. 12, 2025 (GLOBE NEWSWIRE) -- WestKam Gold Corp. (TSXV:WKG) (the “Company” or “WestKam”), is providing a bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). On …
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
GlobeNewswire
·
August 12, 2025
FDA Accepted the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray; New PDUFA Target Date of December 13, 2025 Milestone Strengthens Balance Sheet to Fully Commercialize CARDAMYST if Approved Public Offering Raised Total Gross Proceeds …
Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 12, 2025
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Completed enrollment of Phase 2 MoonStone trial in Relapsing Multiple Sclerosis; results expected early in the fourth quarter 2025 - …
Lithium Argentina and Ganfeng to Form New Joint Venture to Consolidate the Pozuelos and Pastos Grandes Basins
GlobeNewswire
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG. (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) is pleased to announce the execution of a framework agreement (the “Framework Agreement”) with Ganfeng Lithium Group Co. …